EARNEST Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-30
| Closed | -$2.08K | – | 551 |
|
|
2023
Q3 | $2.08K | Hold |
30
| – | – | ﹤0.01% | 990 |
|
|
2023
Q2 | $2.83K | Hold |
30
| – | – | ﹤0.01% | 940 |
|
|
2023
Q1 | $2.48K | Hold |
30
| – | – | ﹤0.01% | 955 |
|
|
2022
Q4 | $2.24K | Hold |
30
| – | – | ﹤0.01% | 982 |
|
|
2022
Q3 | $2K | Hold |
30
| – | – | ﹤0.01% | 963 |
|
|
2022
Q2 | $3K | Sell |
30
-300
| -91% | -$30K | ﹤0.01% | 911 |
|
|
2022
Q1 | $39K | Hold |
330
| – | – | ﹤0.01% | 366 |
|
|
2021
Q4 | $43K | Sell |
330
-180
| -35% | -$23.5K | ﹤0.01% | 357 |
|
|
2021
Q3 | $58K | Hold |
510
| – | – | ﹤0.01% | 323 |
|
|
2021
Q2 | $53K | Hold |
510
| – | – | ﹤0.01% | 329 |
|
|
2021
Q1 | $43K | Hold |
510
| – | – | ﹤0.01% | 343 |
|
|
2020
Q4 | $47K | Hold |
510
| – | – | ﹤0.01% | 323 |
|
|
2020
Q3 | $41K | Buy |
510
+413
| +426% | +$33.2K | ﹤0.01% | 325 |
|
|
2020
Q2 | $7K | Sell |
97
-194
| -67% | -$14K | ﹤0.01% | 641 |
|
|
2020
Q1 | $18K | Hold |
291
| – | – | ﹤0.01% | 399 |
|
|
2019
Q4 | $23K | Hold |
291
| – | – | ﹤0.01% | 413 |
|
|
2019
Q3 | $21K | Hold |
291
| – | – | ﹤0.01% | 430 |
|
|
2019
Q2 | $18K | Hold |
291
| – | – | ﹤0.01% | 469 |
|
|
2019
Q1 | $19K | Hold |
291
| – | – | ﹤0.01% | 448 |
|
|
2018
Q4 | $15K | Hold |
291
| – | – | ﹤0.01% | 463 |
|
|
2018
Q3 | $17K | Hold |
291
| – | – | ﹤0.01% | 458 |
|
|
2018
Q2 | $14K | Hold |
291
| – | – | ﹤0.01% | 495 |
|
|
2018
Q1 | $14K | Hold |
291
| – | – | ﹤0.01% | 491 |
|
|
2017
Q4 | $11K | Buy |
+291
| New | +$11K | ﹤0.01% | 526 |
|
|
2017
Q1 | – | Sell |
-291
| Closed | -$9K | – | 452 |
|
|
2016
Q4 | $9K | Buy |
+291
| New | +$9K | ﹤0.01% | 546 |
|